Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus.
about
The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometryNew insights into the pathophysiology of achalasia and implications for future treatmentChronic constipation: no more idiopathic, but a true neuropathological entity.Achalasia--An Autoimmune Inflammatory Disease: A Cross-Sectional Study.Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia.New techniques in the tissue diagnosis of gastrointestinal neuromuscular diseases.Synopsis of investigations into proposed theories on the etiology of achalasia.The involvement of nitric oxide synthase neurons in enteric neuropathies.Gastrointestinal motility disorders in inflammatory bowel diseases.Muscle layer histopathology and manometry pattern of primary esophageal motility disorders including achalasia.Aspirin prevents atrophy of esophageal nitrergic myenteric neurons in a mouse model of chronic Chagas disease.An Overview of Achalasia and Its Subtypes.Glial regulation of neuronal plasticity in the gut: implications for clinicians.Novel mechanism for impaired nitrergic relaxation in achalasia.Impact of high-resolution manometry on achalasia diagnosis and treatment.Esophageal motility disorders: new perspectives from high-resolution manometry and histopathology.The prevalence of autoimmune disease in patients with esophageal achalasia.Enhanced reactivity of peripheral blood immune cells to HSV-1 in primary achalasia.
P2860
Q27027666-6C4D0714-A8C4-4001-81D8-A24798E68DFBQ28068914-864C34D7-8974-4771-B59A-B29B85CA27BCQ33596276-77178486-57E5-459C-A28E-B45B510BD5F2Q35675896-32965246-1FD7-4011-83C3-D1398262F406Q37166742-5B11585A-FB1C-4357-8104-3A1A2BDD5E6EQ37365362-BAF9AF39-8D96-4AA8-8608-85E7F8882239Q37651098-52F2B931-9CFF-4FB3-BBBA-E8F924C54DA3Q37927166-D0EE4703-A994-4131-A01D-A84310C1FA0CQ38177780-00F1B15E-F285-4B5F-967D-EE7F34249C33Q39325209-15536684-6932-4D97-8FAE-207A2E48AEA0Q40150193-01738671-D577-4B4A-B585-D49BD50CF201Q41531364-7EA8F887-8DD3-4BFB-8B21-7ADBFEBD7E2AQ41858589-229E0FAA-9D18-4AED-9431-DAB88C486274Q42212480-2EFC383B-8A23-4F51-A595-AEF53E6AC6F1Q43100545-FF54FEC4-D5A6-44FD-BD8D-E6B82548D402Q48310910-4AAC229F-6583-4799-8AC4-757069DCEAB9Q51010123-35E7B3D7-83DD-4289-9BAD-34A66894251EQ54429880-C8718017-E5BD-4EB6-B244-2F1E341AEF36
P2860
Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Serum from achalasia patients ...... sponse in normal human fundus.
@ast
Serum from achalasia patients ...... sponse in normal human fundus.
@en
type
label
Serum from achalasia patients ...... sponse in normal human fundus.
@ast
Serum from achalasia patients ...... sponse in normal human fundus.
@en
prefLabel
Serum from achalasia patients ...... sponse in normal human fundus.
@ast
Serum from achalasia patients ...... sponse in normal human fundus.
@en
P2093
P2860
P356
P1433
P1476
Serum from achalasia patients ...... esponse in normal human fundus
@en
P2093
J-C Le Neel
J-P Galmiche
K-H Schafer
M Neunlist
S Bruley des Varannes
P2860
P304
P356
10.1136/GUT.2005.070011
P407
P577
2005-08-16T00:00:00Z